Ambee Pharmaceuticals (DHA:AMBEEPHA) EV-to-EBIT: (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:AMBEEPHA Ambee Pharmaceuticals Plc DHA:AMBEEPHA
18 GF Score
Price BDT802.80
View Full Analysis

What is Ambee Pharmaceuticals EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ambee Pharmaceuticals's Enterprise Value is BDT0.00 Mil. Ambee Pharmaceuticals does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Ambee Pharmaceuticals's EV-to-EBIT at this moment.

The historical rank and industry rank for Ambee Pharmaceuticals's EV-to-EBIT or its related term are showing as below:

DHA:AMBEEPHA's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.855
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Ambee Pharmaceuticals's Enterprise Value for the quarter that ended in . 20 was BDT0.00 Mil. Ambee Pharmaceuticals does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Ambee Pharmaceuticals's Earnings Yield (Joel Greenblatt) % at this moment.

Ambee Pharmaceuticals  (DHA:AMBEEPHA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ambee Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 ) =EBIT / Enterprise Value (Q: . 20 )
=/
= %

Ambee Pharmaceuticals EV-to-EBIT Related Terms

Ambee Pharmaceuticals EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Ambee Pharmaceuticals's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals EV-to-EBIT Chart

Ambee Pharmaceuticals Annual Data
Trend
EV-to-EBIT

Ambee Pharmaceuticals Semi-Annual Data
EV-to-EBIT

DHA:AMBEEPHA vs IMNPQ: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ambee Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ambee Pharmaceuticals EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ambee Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ambee Pharmaceuticals's EV-to-EBIT falls into.


DHA:AMBEEPHA
18GF Score
Ambee Pharmaceuticals Plc DHA:AMBEEPHA
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambee Pharmaceuticals EV-to-EBIT Calculation

Ambee Pharmaceuticals's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/
=

Ambee Pharmaceuticals Business Description

Address 184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.
18GF Score

Get the complete analysis for DHA:AMBEEPHA

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT802.80
Price